Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 37.80
+0.10 (0.27%)
Sep 12, 2025, 1:30 PM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 29.12 billion as of September 12, 2025. Its market cap has decreased by -32.55% in one year.
Market Cap
29.12B
Enterprise Value
29.75B
Revenue
64.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.80
Market Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 29.12B, a decrease of -37.31%. That is a compound annual growth rate of -4.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 29.12B | -14.51% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | 11.20B | -8.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 355.96B |
| PharmaEssentia | 179.30B |
| Bora Pharmaceuticals Co., LTD. | 91.71B |
| Lotus Pharmaceutical | 50.62B |
| Lumosa Therapeutics | 48.43B |
| Oneness Biotech | 36.35B |
| Center Laboratories | 28.21B |
| Pell Bio-Med Technology | 26.52B |